Holen Sie sich die Stockscreener-App
209.52
0.16%
0.33
Handel nachbörslich:
209.52
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DHR?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$209.19
Offen:
$210.34
24-Stunden-Volumen:
2.31M
Relative Volume:
0.62
Marktkapitalisierung:
$148.11B
Einnahmen:
$24.57B
Nettoeinkommen (Verlust:
$3.60B
KGV:
41.51
EPS:
5.0475
Netto-Cashflow:
$5.25B
1W Leistung:
+0.46%
1M Leistung:
-10.85%
6M Leistung:
+0.87%
1J Leistung:
-0.42%
1-Tages-Spanne:
$208.94
$211.04
1-Wochen-Bereich:
$206.31
$212.69
52-Wochen-Spanne:
$171.00
$242.80
Danaher Corp Stock (DHR) Company Profile
Firmenname
Danaher Corp
Sektor
Branche
Telefon
(202) 828-0850
Adresse
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
209.52 | 147.88B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
TMO
Thermo Fisher Scientific Inc
|
513.68 | 193.72B | 44.56B | 6.73B | 6.29B | 17.74 |
|
IDXX
Idexx Laboratories Inc
|
657.38 | 51.84B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
124.72 | 35.19B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.44 | 32.01B | 3.17B | 642.63M | 516.49M | 10.77 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-08 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2025-03-14 | Hochstufung | Stifel | Hold → Buy |
| 2025-02-03 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-31 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Eingeleitet | HSBC Securities | Hold |
| 2023-12-13 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2023-12-07 | Herabstufung | Goldman | Buy → Neutral |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-01 | Eingeleitet | SVB Securities | Outperform |
| 2023-04-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-10-24 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-08-17 | Fortgesetzt | Bernstein | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-06-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Eingeleitet | Bernstein | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-10 | Bestätigt | BofA Securities | Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Bestätigt | Goldman | Buy |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-04-07 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-03-03 | Fortgesetzt | Barclays | Overweight |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Fortgesetzt | Stifel | Hold |
| 2019-10-28 | Bestätigt | Needham | Buy |
| 2019-10-14 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-07-19 | Bestätigt | Needham | Buy |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-04-17 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2019-02-25 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Needham | Buy |
| 2018-04-20 | Bestätigt | Stifel | Buy |
Alle ansehen
Danaher Corp Aktie (DHR) Neueste Nachrichten
Cytiva expands Fast Trak process development and validation services facility in India - Pharmabiz.com
[Form 4] DANAHER CORP /DE/ Insider Trading Activity - Stock Titan
Masimo's board backs Danaher's $9.9B cash acquisition proposal - MSN
Danaher Corporation (NYSE:DHR) to Issue Dividend Increase$0.40 Per Share - MarketBeat
Waratah Capital Advisors Ltd. Grows Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Acquired by RWA Wealth Partners LLC - MarketBeat
How Is Danaher Corporation’s Stock Performance Compared to other Health Care Stocks? - Barchart.com
Decoding Danaher Corp (DHR): A Strategic SWOT Insight - GuruFocus
Danaher declares $0.40 quarterly dividend per share - Investing.com
Danaher Corp announces quarterly dividend of $0.40 per share - marketscreener.com
Insider Trends: Is Danaher Corporation stock a hidden gem2025 Institutional Moves & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Danaher Raises Quarterly Dividend 25% - marketscreener.com
Danaher declares $0.40 quarterly dividend per share By Investing.com - Investing.com South Africa
Leica Biosystems launches next-gen cryostat with faster cooling, lower energy use - R&D World
Danaher to pay shareholders $0.40 per share in April dividend - Stock Titan
Danaher to Present at TD Cowen Health Care Conference - Yahoo Finance
All-Cash Masimo Deal Offers Strong Strategic Fit For Danaher Corporation (DHR) - Finviz
Masimo Buyout By Danaher Spurs Revaluation And Volatility Questions - Yahoo Finance
Danaher (DHR) is Gaining from Improvement in Its Bioprocessing Business - Insider Monkey
First Financial Bankshares Inc Raises Stock Holdings in Danaher Corporation $DHR - MarketBeat
Generation Investment Management LLP Has $1.32 Billion Stock Position in Danaher Corporation $DHR - MarketBeat
Equitable Trust Co. Has $1.42 Million Holdings in Danaher Corporation $DHR - MarketBeat
Best Biotech Stocks To Follow Now – February 22nd - Defense World
Top Biotech Stocks To Keep An Eye On – February 21st - Defense World
Masimo Set to Join Beckman Owner, Danaher, in $9.9 Billion Deal - Orange County Business Journal
OC Insider: Danaher Doubles Up - Orange County Business Journal
The Zacks Analyst Blog Highlights Philip Morris, Lockheed Martin, Danaher and Zeo Energy - Nasdaq
Best Biotech Stocks To Follow NowFebruary 22nd - MarketBeat
Danaher to acquire Masimo for $9.9 billion - DOTmed
Payden & Rygel Lowers Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Stock Position Trimmed by LaFleur & Godfrey LLC - MarketBeat
Clearstead Advisors LLC Grows Stock Position in Danaher Corporation $DHR - Defense World
Danaher Aktie: 10-Milliarden-Dollar-Deal - sharewise.com
Top Biotech Stocks To Keep An Eye OnFebruary 21st - MarketBeat
Biotech Stocks To Follow TodayFebruary 20th - MarketBeat
Zeno Equity Partners LLP Buys 6,856 Shares of Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Sold by Kovitz Investment Group Partners LLC - MarketBeat
Journey Advisory Group LLC Sells 12,079 Shares of Danaher Corporation $DHR - MarketBeat
Fiera Capital Corp Decreases Position in Danaher Corporation $DHR - MarketBeat
CenterBook Partners LP Reduces Stock Holdings in Danaher Corporation $DHR - MarketBeat
Insider Selling: Danaher (NYSE:DHR) EVP Sells 1,320 Shares of Stock - MarketBeat
Top Analyst Reports for Philip Morris, Lockheed Martin & Danaher - Yahoo Finance
Deal Dispatch: Starboard Targets TripAdvisor, His & Hers Expands, Mister Car Wash Goes Private - Benzinga
Taxation With Representation: Freshfields, Simpson Thacher - Law360
Leica launches CM1950 cryostat with DualEcoTec cooling system - Medical Design & Outsourcing
Danaher Drops $10B to Snatch Masimo in Diagnostics Push - Dealbreaker
Rx Rundown: Danaher, Johnson & Johnson, Bayer and more - Medical Marketing and Media
Danaher to Acquire Masimo Corp. for $9.9B | Business | Feb 2026 - Photonics Spectra
Elefante Mark B Acquires 2,418 Shares of Danaher Corporation $DHR - Defense World
Danaher deal finalized: Company to acquire Masimo for $9.9 billion in cash - MSN
Danaher to buy Masimo in $9.9 billion deal in diagnostics push - MSN
Finanzdaten der Danaher Corp-Aktie (DHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.37%
1.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):